Skip to content
Will the evidence from psychedelic medicine research move politicians to develop a more rational and progressive drug policy?

Details

  • Main Stage
Date:
11/04/2022
Start Time:
9:30 am
End Time:
10:10

Daniel Martinez, Esq.

Congressional Candidate: CA-31

He is running for Congress on a platform that includes the reduction of Veteran Suicide as a top priority. His intention is to use his platform to shine a spotlight on the legal/regulatory/bureaucrati…

Melissa Lavasani

Founder and Executive Director, Psychedelic Medicine Coalition

Melissa Lavasani is the Founder and Executive Director of Psychedelic Medicine Coalition, a Washington DC-based organization advocating for all plant medicines and their synthetic derivatives at the N…

Christopher Koddermann

Co-founder and Chair of the Board of Directors, International Therapeutic Psilocybin Rescheduling Initiative, CURA Communications

Christopher Koddermann is the Co-founder and Chair of Board of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition launched to pursue and secure a rescheduling…

Najla Guthrie

CEO, KGK Science

Throughout her career, Najla Guthrie has been hailed for both her revolutionary contributions to nutritional science and her accomplishments within the nutraceutical industry. Her original research, w…

Dr. Jeanne Fontana

CEO, Founder, Be Herd Foundation

Dr. Fontana has service on Boards of Trustees of well-established medical research institutes, several medical nonprofits, and serving as senior advisor to health and wellness media companies. She hol…

Gregory Ferenstein

CEO, Frederick Research

Gregory Frederick Ferenstein, M.Sc. has been writing on innovation and psychology for over a decade. His peer-reviewed research was published in the leading journal of its field and his work appears i…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now